CAS: 64-86-8; N-[(7S)-1,2,3,10-Tetramethoxy-9-Oxo-6,7-Dihydro-5H-Benzo[a]Heptalen-7-Yl]Acetamide

该化合物是用于治疗甲状腺热和家庭性地中海热的植物衍生的碱性藻类. 其关键优势包括快速行动,高效减少炎症和疼痛以及预防照明弹的能力. 由于潜在的肠胃肠胃副作用,它常常被规定为短期用途.

结构式图片

欧盟法规

统一分类与标签压力设备指令-第1组危险流体REACH注册ECHA物质ECHA物质工作场所安全标识要求食品接触材料-禁用CMR物质C&L通报化妆品禁用物质清单REACH预注册废弃物危险特性清单

上下游产品

CAS号108-24-7 乙酸酐 | CAS号53560-26-2 3-(3,4,5-TRIMET... | CAS号327025-17-2 triisopropyl(3-... | CAS号327025-04-7 5-(3-triisoprop... | CAS号4521-61-3 3,4,5-三甲氧基苯甲酰氯 | CAS号327025-09-2 (2S)-methyl-[2-... | CAS号327024-99-7 3-(2-ethynyl-3,... | CAS号206195-25-7 3-(2-ethynyl-3,... | CAS号206195-28-0 3-(2-ethynyl-3,... | CAS号3476-50-4 Trimethylcolchi... | CAS号3482-37-9 三甲基秋水仙酸 | CAS号477-30-5 秋水仙胺 | CAS号1850-57-3 5,6-Dihydro-1,2... | CAS号2826-80-4 Acetamide,N-[(7... | CAS号2730-82-7 Acetamide,N-[(7... | CAS号2731-16-0 Benzo[a]heptale... | CAS号87424-25-7 3-demethylthi°C... | CAS号518-11-6 COLCHICEINE, N-... | CAS号3123-89-5 Acetamide,N-[(7...

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2004242897-A1
    优先权日:2002-07-31
    标题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-7094913-B2
    优先权日:2003-09-17
    标题:Synthesis of 7-membered carbocyclic compound having diexomethylene groups
    发明人:CHO YONG SEO; CHANG MOON HO; KOH HUN YEONG; PAE AE NIM; KANG HYUN JUNG
    权利人:KOREA INST SCI & TECH
    摘要:The present invention relates to a synthesis of a 7-membered carbocyclic compound having diexomethylene groups, more particularly to a synthesis of a 7-membered carbocyclic compound having diexomethylene groups, a novel compound having the structure represented by the following Chemical Formula 1, from trimethylsilanylmethyl-allenol derivative by the intramolecular Prins cyclization using Lewis acid. The 7-membered carbocyclic compound is a useful intermediate for synthesis of other multicyclic compounds. n n n n n n n n n n In Chemical Formula 1, R 1 is a C 1 to C 6 alkyl group, and R 2 and R 3 is respectively a hydrogen atom, or R 1 , R 2 and R 3 may be connected with neighboring substituents to form a 5 to 10-membered aliphatic or aromatic ring.

    专利号:WO-2004011474-A1
    优先权日:2002-07-31
    标题:Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-11912647-B2
    优先权日:2020-05-22
    标 题:Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation
    发明人:CRICH DAVID; HETTIKANKANAMALAGE ASIRI; HILL JARVIS
    权利人:UNIV GEORGIA
    摘要:In one aspect, the disclosure relates to a method for the direct synthesis of complex N,N,O-trisubstituted hydroxylamines by N—O bond formation. In another aspect, the method can successfully be employed using a wide variety of commercially available alcohols and secondary amines and enables the construction of large fragment-based libraries of trisubstituted hydroxylamines for drug discovery purposes. Also disclosed are N,N,O-trisubstituted hydroxylamines having low basicity, high stability at ambient temperatures, and an inherent lack of reactivity towards acetylating and sulfonylating enzymes that confer mutagenicity on less-substituted hydroxylamines.

    专利号:US-6653468-B1
    优先权日:2002-07-31
    标 题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    权利人:ISIS PHARMACEUTICALS INC
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
    陕西绿清生物工程有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sxgreenfine.com
    电话: 0086 (29) 8621-5910/20/30👤
    📞陕西绿清生物工程有限公司 ⚠️参考联系方式

    销售电话:0086 (29) 8621-5910/20/30
    邮箱:sarali@sxgreenfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:西安市凤城一路177号鼎新花园A5404
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    陕西慧科植物开发有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.huikes.com
    电话: 0086-4000-999-369👤
    📞陕西慧科植物开发有限公司 ⚠️参考联系方式

    销售电话:0086-4000-999-369
    邮箱:marketing@huikes.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京梅尔森医药技术开发有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjmerson.com
    电话: 086-10-80484574,80483447👤
    📞北京梅尔森医药技术开发有限公司 ⚠️参考联系方式

    销售电话:086-10-80484574,80483447
    邮箱:sales@bjmerson.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    成都健腾生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aktinchem.com
    电话: 86-28-85159085👤
    📞成都健腾生物技术有限公司 ⚠️参考联系方式

    销售电话:86-28-85159085
    邮箱:info@aktinchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北猫尔沃生物医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.marvel-bio.com
    企业联系电话:15387162023👤
    📞湖北猫尔沃生物医药有限公司 ⚠️参考联系方式
    联系人:宋经理
    电话:15387162023
    手机:15387162023
    传真:027-877288767
    邮箱:1824363398@qq.com
    通信地址: 湖北省高新技术开发区关山大道
    邮编: 430070
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省高新技术开发区关山大道
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海展云化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shzychem.com
    企业联系电话:021-56651122👤
    📞上海展云化工有限公司 ⚠️参考联系方式
    联系人:周明
    电话:021-56651122
    手机:13506150053
    传真:021-66311090
    邮箱:657690972@qq.com
    通信地址: 上海市宝山区南大路586号3楼
    邮编: 155100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市宝山区南大路586号3楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Yeh LC, Banerjee A, Prasad V, Tuszynski JA, Weis AL, Bakos T, Yeh IT, Ludueña RF, Lee JC. Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulin. Invest New Drugs. 2015 Dec 21. [Epub ahead of print] doi: 10.1097/MD.0000000000001570. doi: 10.4103/0975-7406.168021.
    4: Izadi Amoli A, Bozorgi A, HajHossein Talasaz A, Salehi Omran A, Mortazavi SH, Jalali A, Nasirpour S, Jenab Y. Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: A randomized, placebo-controlled trial. Am Heart J. 2015 Dec;170(6):1195-201. doi: 10.1016/j.ahj.2015.09.020. Epub 2015 Oct 3. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims. Ann Rheum Dis. 2015 Nov 18. pii: annrheumdis-2015-207984. doi: 10.1136/annrheumdis-2015-207984. [Epub ahead of print] Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare. Curr Med Chem. 2015 Nov 17. [Epub ahead of print] Impact of glomerular filtration rate in colchicine toxicity. Semin Arthritis Rheum. 2015 Oct 22. pii: S0049-0172(15)00248-6. doi: 10.1016/j.semarthrit.2015.09.012. [Epub ahead of print]

    合成参考文献


    参考文献:10.1186/2047-783x-14-s4-259
    摘要:Zielonka T, Demkow U, Zycinska K, Filewska M, Bialas B, Kus J, Radzikowska E, Remiszewski P, Szopinski J, Soszka A, Wardyn K, Skopinska-Rozewska E. Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes. European Journal of Medical Research. 2009 Dec 07;14(Suppl 4):259. doi: 10.1186/2047-783x-14-s4-259.
    摘要:Beselia G, Maglakelidze G, Chkhikvishvili N, Burjanadze M, Dashniani M. Object exploration and reactions to spatial and nonspatial changes in dentate gyrus lesioned rats. Georgian Med News. 2010 Jan;(178):61–5.
    参考文献:10.1007/s10165-011-0497-5|10.3109/s10165-011-0497-5
    摘要:Hirano T, Ohguro N, Hohki S, Hagihara K, Shima Y, Narazaki M, Ogata A, Yoshizaki K, Kumanogoh A, Kishimoto T, Tanaka T. A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Mod Rheumatol. 2012 Apr;22(2):298–302. doi: 10.1007/s10165-011-0497-5.
    参考文献:10.1371/journal.pone.0020841
    摘要:Larkum AWD, Salih A, Kühl M. Rapid Mass Movement of Chloroplasts during Segment Formation of the Calcifying Siphonalean Green Alga, Halimeda macroloba. PLoS ONE. 2011 Jul 05;6(7):e20841. doi: 10.1371/journal.pone.0020841.
    参考文献:10.1007/s00299-011-1085-z
    摘要:Cai X, Kang XY. In vitro tetraploid induction from leaf explants of Populus pseudo-simonii Kitag. Plant Cell Rep. 2011 Sep;30(9):1771–8. doi: 10.1007/s00299-011-1085-z.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知